Request Deal Involvement

RA Capital Management led a £60m funding round in Alchemab Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Instinctif Partners

pr advisors

Instinctif Partners

Latham & Watkins

legal advisors

Latham & Watkins

or

Principals

ALCHEMAB THERAPEUTICS

target

ALCHEMAB THERAPEUTICS

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

SV HEALTH INVESTORS

bidder

SV HEALTH INVESTORS

LIGHTSTONE VENTURES

bidder

LIGHTSTONE VENTURES

DEMENTIA DISCOVERY

bidder

DEMENTIA DISCOVERY

DHVC

bidder

DHVC

DATA COLLECTIVE (DCVC)

bidder

DATA COLLECTIVE (DCVC)

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - RA Capital Management led a £60m funding round in Alchemab Therapeutics.